Physicians' Academy for Cardiovascular Education

The evolving need and challenges to reach LDL-c targets in high-risk patients

10' education - Sep. 14, 2023 - Kausik Ray, MD - London, UK

Video navigation menu

  • Relevance of cholesterol to CVD mortality 00:28
  • Estimating benefit of initiating LDL-c lowering at different ages 02:08
  • Conceptual framework shift 03:53
  • Data on LDL-c goal attainment and use of combination therapy  05:07
  • Conclusions 08:50


Show transcript

Educational information

This lecture by Prof. Kausik Ray was part of the EBAC-accredited symposium "The LDL-c challenge in high cardiovascular risk: Integrating innovative therapies in clinical management" held during the ESC congress 2023.


Prof. Kausik Ray, MD, is president of the European Atherosclerosis Society, and Professor of Public Health/ Consultant Cardiologist at Imperial College London, United Kingdom.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant from Amgen, NewAmsterdam Pharma, Sanofi and Viatris.

View the slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: